fullerene c60 has been researched along with Neoplasms in 66 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (15.15) | 29.6817 |
2010's | 42 (63.64) | 24.3611 |
2020's | 14 (21.21) | 2.80 |
Authors | Studies |
---|---|
Cholewinski, G; Dzierzbicka, K; Gensicka-Kowalewska, M; Siebert, A | 1 |
Buma, WJ; Kong, X; Liu, X; Sun, Z; Zeng, Q; Zhang, H; Zhang, Y; Zheng, M | 1 |
Avci, P; Chiang, LY; Hamblin, MR; Huang, HC; Huang, YY; Wang, M; Yin, R | 1 |
Agrawal, T; Chiang, LY; Hamblin, MR; Huang, YY; Sharma, SK; Yin, R | 1 |
Hong, L; Li, H; Li, Q; Liu, C | 1 |
Fu, Y; Lu, T; Shi, J; Wang, B; Wang, L; Zhang, H; Zhang, Z | 1 |
Li, Y; Man, N; Shen, Y; Sun, K; Wen, LP; Yang, W; Zhang, Q; Zheng, F | 1 |
Lu, Y; Man, N; Wei, P; Wen, L; Zhang, L | 1 |
Chen, R; Metanawin, T; Tang, T; Vernon, D; Wang, X | 1 |
Guan, W; Hu, Z; Huang, Y; Sun, S; Yao, Y; Zhang, C | 1 |
Gedik, ME; Günaydın, G; Gündüz, EÖ; Okutan, E | 1 |
Chang, L; Liu, S; Meng, X; Plant, LD; Su, J; Wang, X; Wu, C; Yang, N | 1 |
Akiyoshi, K; Hirano, H; Ikeda, A; Isozaki, H; Katagiri, K; Kawamura, S; Kawasaki, R; Kondo, K; Miura, R; Nishimura, T; Sasaki, Y; Sawada, SI; Shimada, R; Stubelius, A; Tarutani, N; Yamana, K | 1 |
Grebowski, J; Litwinienko, G | 1 |
DCruz, CEM; Fernandes, NB; Kajampady, MK; Kumar, L; Shenoy, RUK; Shirodkar, RK; Verma, R | 1 |
Lai, C; Li, L; Luo, B; Shao, J; Shen, J | 1 |
Al Garalleh, H | 1 |
Balin, K; Calvaresi, M; Korzuch, J; Malarz, K; Marforio, TD; Mrozek-Wilczkiewicz, A; Musiol, R; Serda, M | 1 |
Dreszer, D; Korzuch, J; Krzykawska-Serda, M; Musioł, R; Serda, M | 1 |
Abu-Serie, MM; Ali, SM; El Fawal, G; Elessawy, NA | 1 |
Dong, X; Gu, R; Huang, H; Shi, H; Si, W; Wang, W; Xu, W; Xue, L; Zhang, Y | 1 |
Bai, C; Jia, W; Li, L; Liu, S; Sun, Z; Wang, C; Wang, H; Zhao, Z; Zhen, M; Zhou, C | 1 |
Fahmy, TM; Gim, G; Kim, HH; Kim, HI; Kim, JH; Kim, SR; Lee, C; Lee, H; Lee, J; Moor, KJ; Seok Lee, J | 1 |
Fu, S; Ma, Y; Tan, Y; Zhang, A | 1 |
Guo, W; Kollie, L; Liu, X; Yang, S; Ye, L; Ying, X; Yu, M; Zhu, J | 1 |
Augustine, S; Das, A; Malhotra, BD; Sharma, M; Singh, J; Srivastava, M | 1 |
Bagheri, Z; Hazrati, MK; Javanshir, Z | 1 |
Gutiérrez-Flores, J; Minutti, B; Morales, G; Moreno, A; Ramos, E; Rios, C; Salcedo, R; Suarez, A; Vázquez, FJ | 1 |
Hu, R; Huang, C; Li, Q; Liu, L; Qu, J | 1 |
Chen, X; Chen, ZY; Fu, X; Jacobson, O; Liu, Y; Shen, Z; Wang, S; Wang, Z; Zhou, Z | 1 |
Wang, C; Wang, T | 1 |
Chen, D; Deng, R; Ge, J; Guan, M; Li, X; Liu, S; Shu, C; Sun, D; Wang, C; Xu, H; Yu, T; Zhao, J; Zhou, Y; Zou, T | 1 |
Hashimoto, A; Oda, Y; Takamura-Enya, T | 1 |
Chen, L; Chen, Z; Gu, Z; Li, J; Su, H; Yan, L; Zhang, A; Zhao, F; Zhao, Y | 1 |
Grebowski, J; Kazmierska, P; Krokosz, A | 1 |
Gao, J; Liu, R; Liu, Y; Ma, R; Shi, J; Wang, L; Zhang, J; Zhang, Z | 1 |
Araya-Secchi, R; Huynh, T; Kang, SG; Wang, B; Wang, D; Zhou, R | 1 |
Chen, C; Ding, R; Guo, X; Liu, X; Ye, L; Zhang, Y; Zhang, Z | 1 |
Bao, M; Cui, X; Li, X; Lou, Z; Wang, F; Zhao, J | 1 |
Duan, J; Jiang, G; Li, G; Yin, F | 1 |
Da Ros, T; Grillo, A; Lucafò, M; Pacor, S; Prato, M; Sava, G; Zorzet, S; Đorđević, L | 1 |
Ikeda, A | 1 |
Bai, R; Chen, C; Chen, Z; Dong, J; Liu, J; Liu, Y; Miao, Q; Sun, B; Tang, J; Wang, L; Zhao, Y; Zhou, H | 1 |
Chen, D; Guan, M; Guan, X; Han, H; Shu, C; Wang, C; Zhang, Y; Zhen, M; Zou, T | 1 |
Krokosz, A; Lichota, A | 1 |
Chen, C; Fu, PP; Gao, X; Lao, F; Liang, XJ; Meng, J; Sun, B; Wang, PC; Xing, G; Yin, JJ; Zhao, Y | 1 |
Churnosov, MI; Karapetian, TA; Shirinkin, SV | 1 |
Fukamachi, K; Futakuchi, M; Sakai, Y; Tsuda, H; Xu, J | 1 |
Chai, Z; Chen, C; Chen, Z; Lei, H; Li, W; Liang, X; Long, J; Meng, H; Song, Y; Sun, B; Wang, X; Xing, G; Yuan, H; Zhang, N; Zhao, F; Zhao, Y | 1 |
Baeuerle, T; Bock, M; Braun, K; Dunsch, L; Pipkorn, R; Waldeck, W; Wiessler, M; Yang, S | 1 |
Hu, Z; Li, S; Yan, L; Zhao, F; Zhao, Y | 1 |
Alonso, CM; Boyle, RW; Bullous, AJ | 1 |
Chiang, LY; Hamblin, MR; Sharma, SK | 1 |
Chen, Z; Liu, Y; Mao, R | 1 |
Kwag, DS; Lee, ES; Oh, KT; Oh, NM; Oh, YT; Youn, YS | 1 |
Balabathula, P; Bhattacharjee, H; Wood, GC | 1 |
Chen, X; Liang, X; Meng, J; Zhao, Y | 1 |
Chen, C; Hou, L; Li, L; Li, Z; Shi, J; Wang, H; Wang, L; Wang, Z; Zhang, C; Zhang, H; Zhang, Z | 1 |
Kwag, DS; Lee, ES; Oh, KT; Park, K | 1 |
Huynh, T; Kang, SG; Zhou, R | 1 |
Chai, Z; Chen, C; Chen, Z; Fang, X; Gao, Y; Li, B; Li, Y; Ma, B; Meng, H; Sun, J; Tang, J; Wan, L; Wang, J; Xing, G; Ye, C; Yu, H; Yuan, H; Zhao, Y; Zhu, C | 1 |
Chen, Y; Dougherty, TJ; Goswami, LN; Gryshuk, A; Missert, JR; Oseroff, A; Pandey, RK | 1 |
Liu, J; Murata, K; Nitta, N; Ohta, S; Sonoda, A; Tabata, Y; Yamada, M; Yamamoto, M | 1 |
Gali, H; Hamblin, MR; Lee, H; Mroz, P; Pawlak, A; Sarna, T; Satti, M; Wharton, T | 1 |
Gali, H; Hamblin, MR; Mroz, P; Sarna, T; Tegos, GP; Wharton, T | 1 |
Hartman, KB; Wilson, LJ | 1 |
22 review(s) available for fullerene c60 and Neoplasms
Article | Year |
---|---|
Tuftsin - Properties and Analogs.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Colitis; Cytokines; Fullerenes; Humans; Mycobacterium tuberculosis; Neoplasms; T-Lymphocytes; Tuftsin | 2017 |
Functionalized fullerenes in photodynamic therapy.
Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; Fullerenes; Humans; Neoplasms; Photochemotherapy; Photosensitizing Agents | 2014 |
Metallofullerenols in biomedical applications.
Topics: Contrast Media; Fullerenes; Gadolinium; Humans; Magnetic Resonance Imaging; Neoplasms | 2022 |
Fullerenes for the treatment of cancer: an emerging tool.
Topics: Fullerenes; Humans; Neoplasms; Photochemotherapy; Photosensitizing Agents | 2022 |
Current Advances and Prospects in Carbon Nanomaterials-based Drug Deliver Systems for Cancer Therapy.
Topics: Drug Delivery Systems; Fullerenes; Humans; Nanostructures; Nanotubes, Carbon; Neoplasms; Pharmaceutical Preparations | 2023 |
Antitumor Activity and Potential Mechanism of Novel Fullerene Derivative Nanoparticles.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Design; Drug Screening Assays, Antitumor; Fullerenes; Humans; Mice; Nanomedicine; Nanoparticles; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic | 2021 |
Recent advances in carbon based nanosystems for cancer theranostics.
Topics: Animals; Carbon; Drug Delivery Systems; Fullerenes; Graphite; Humans; Models, Molecular; Nanostructures; Nanotubes, Carbon; Neoplasms; Optical Imaging; Photoacoustic Techniques; Positron-Emission Tomography; Theranostic Nanomedicine | 2017 |
Enhancing Type I Photochemistry in Photodynamic Therapy Under Near Infrared Light by Using Antennae-Fullerene Complexes.
Topics: Fullerenes; Humans; Neoplasms; Photochemistry; Photochemotherapy; Reactive Oxygen Species; Spectroscopy, Near-Infrared | 2018 |
Functional Metallofullerene Materials and Their Applications in Nanomedicine, Magnetics, and Electronics.
Topics: Animals; Electronics; Fullerenes; Humans; Magnetics; Metals; Nanomedicine; Neoplasms | 2019 |
The pharmaceutical multi-activity of metallofullerenol invigorates cancer therapy.
Topics: Contrast Media; Coordination Complexes; Fullerenes; Gadolinium; Humans; Nanomedicine; Neoplasms; Neoplastic Stem Cells; Reactive Oxygen Species; Tumor Microenvironment | 2019 |
Fullerenols as a new therapeutic approach in nanomedicine.
Topics: Anthracyclines; Drug Carriers; Fullerenes; Humans; Nanomedicine; Neoplasms; Neurodegenerative Diseases; Oxidative Stress; Water | 2013 |
Photodynamic Activity of Fullerenes and Other Molecules Incorporated into Lipid Membranes by Exchange.
Topics: Drug Carriers; Fullerenes; Humans; Lipid Bilayers; Liposomes; Membrane Lipids; Molecular Structure; Neoplasms; Photochemotherapy; Solubility; Water | 2016 |
[Fullerenols in therapy and diagnosis of cancer].
Topics: Antineoplastic Agents; Fullerenes; Humans; Neoplasms; Poland | 2016 |
[Fullerenes in the treatment of respiratory disorders].
Topics: Free Radicals; Fullerenes; Humans; Neoplasms; Pulmonary Disease, Chronic Obstructive; Respiration Disorders | 2008 |
Toxicology of engineered nanomaterials - a review of carcinogenic potential.
Topics: Animals; Carcinogens; Environmental Exposure; Foreign-Body Reaction; Fullerenes; Inhalation Exposure; Mice; Nanostructures; Nanotechnology; Neoplasms; Rats; Risk Assessment; Soot; Titanium | 2009 |
Photosensitiser-antibody conjugates for photodynamic therapy.
Topics: Acrylamides; Antibodies; Carbodiimides; Fullerenes; Humans; Isothiocyanates; Neoplasms; Photochemotherapy; Photosensitizing Agents; Polyglutamic Acid; Polyvinyl Alcohol | 2011 |
Fullerenes for cancer diagnosis and therapy: preparation, biological and clinical perspectives.
Topics: Animals; Antineoplastic Agents; Fullerenes; Humans; Neoplasms | 2012 |
Targeted nanoparticulate drug-delivery systems for treatment of solid tumors: a review.
Topics: Antineoplastic Agents; Dendrimers; Drug Delivery Systems; Emulsions; Fullerenes; Humans; Liposomes; Micelles; Nanoparticles; Neoplasms | 2010 |
Biological characterizations of [Gd@C82(OH)22]n nanoparticles as fullerene derivatives for cancer therapy.
Topics: Fullerenes; Gadolinium; Humans; Metal Nanoparticles; Nanocapsules; Neoplasms | 2013 |
Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy.
Topics: Bacteriochlorophyll A; Chlorophyll; Diagnostic Imaging; Fullerenes; Humans; Neoplasms; Photochemotherapy; Photosensitizing Agents | 2006 |
Photodynamic therapy with fullerenes.
Topics: Animals; DNA Breaks; Fullerenes; Humans; Membranes; Mutation; Neoplasms; Photobiology; Photochemistry; Photochemotherapy; Staphylococcus aureus; Viruses | 2007 |
Carbon nanostructures as a new high-performance platform for MR molecular imaging.
Topics: Carbon; Contrast Media; Fullerenes; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Models, Chemical; Nanoparticles; Nanostructures; Nanotechnology; Nanotubes; Nanotubes, Carbon; Neoplasms | 2007 |
44 other study(ies) available for fullerene c60 and Neoplasms
Article | Year |
---|---|
Separately doped upconversion-C60 nanoplatform for NIR imaging-guided photodynamic therapy of cancer cells.
Topics: Cell Line, Tumor; Cell Survival; Fluorescence Resonance Energy Transfer; Fullerenes; HeLa Cells; Humans; Infrared Rays; Lanthanoid Series Elements; Metal Nanoparticles; Nanoconjugates; Neoplasms; Photochemotherapy | 2013 |
Photodynamic therapy with decacationic [60]fullerene monoadducts: effect of a light absorbing electron-donor antenna and micellar formulation.
Topics: Fullerenes; HeLa Cells; Humans; Micelles; Neoplasms; Photochemotherapy | 2014 |
Graphene oxide-fullerene C
Topics: Cell Survival; Fullerenes; Graphite; HeLa Cells; Humans; Infrared Rays; Neoplasms; Oxides; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Reactive Oxygen Species | 2017 |
Fullerene (C60)-based tumor-targeting nanoparticles with "off-on" state for enhanced treatment of cancer.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Doxorubicin; Drug Delivery Systems; Female; Fullerenes; Mice; Mice, Inbred BALB C; Neoplasms; Phosphatidylethanolamines; Polyethylene Glycols; Reactive Oxygen Species; Tumor Burden | 2016 |
Autophagy-mediated chemosensitization in cancer cells by fullerene C60 nanocrystal.
Topics: Animals; Autophagy; Autophagy-Related Protein 5; Cell Line, Transformed; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fibroblasts; Fullerenes; Humans; Light; Mice; Microscopy, Electron, Transmission; Microtubule-Associated Proteins; Nanoparticles; Neoplasms; Reactive Oxygen Species | 2009 |
C60(Nd) nanoparticles enhance chemotherapeutic susceptibility of cancer cells by modulation of autophagy.
Topics: Animals; Autophagy; Cell Death; Cell Line, Transformed; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Fullerenes; Green Fluorescent Proteins; HeLa Cells; Humans; Mice; Microtubule-Associated Proteins; Nanomedicine; Nanoparticles; Neoplasms; Reactive Oxygen Species; Sirolimus | 2010 |
Cytotoxicity and photocytotoxicity of structure-defined water-soluble C60/micelle supramolecular nanoparticles.
Topics: Cell Line, Tumor; Cell Survival; Fullerenes; Humans; Micelles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Solubility; Water | 2011 |
Photodynamic anticancer activities of water-soluble C(60) derivatives and their biological consequences in a HeLa cell line.
Topics: Antineoplastic Agents; Apoptosis; Arginine; Caspase 3; Catalase; Cell Survival; Folic Acid; Fullerenes; Glutathione Peroxidase; HeLa Cells; Humans; Light; Malondialdehyde; Membrane Potential, Mitochondrial; Neoplasms; Phenylalanine; Photochemotherapy; Reactive Oxygen Species; Superoxide Dismutase; Water | 2012 |
Amphiphilic Fullerene-BODIPY Photosensitizers for Targeted Photodynamic Therapy.
Topics: Boron Compounds; Fullerenes; Glucose; Humans; Neoplasms; Photochemotherapy; Photosensitizing Agents; Singlet Oxygen | 2022 |
The Molecular Mechanism of Human Voltage-Dependent Anion Channel 1 Blockade by the Metallofullerenol Gd@C
Topics: Antineoplastic Agents; Fullerenes; Gadolinium; Humans; Neoplasms; Organometallic Compounds; Voltage-Dependent Anion Channel 1 | 2022 |
Theranostic Agent Combining Fullerene Nanocrystals and Gold Nanoparticles for Photoacoustic Imaging and Photothermal Therapy.
Topics: Animals; Cell Line, Tumor; Fullerenes; Gold; Humans; Metal Nanoparticles; Mice; Nanoparticles; Neoplasms; Photoacoustic Techniques; Phototherapy; Photothermal Therapy; Precision Medicine; Theranostic Nanomedicine | 2022 |
Fullerene Derivatives (C
Topics: Antineoplastic Agents; Doxorubicin; Fullerenes; Hydroxides; Nanotubes, Carbon; Neoplasms; Pharmaceutical Preparations | 2022 |
Identification and Biological Evaluation of a Water-Soluble Fullerene Nanomaterial as BTK Kinase Inhibitor.
Topics: Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Agents; Caspases; Fullerenes; Glycine; Hematologic Neoplasms; Humans; Neoplasms; Protein Kinase Inhibitors; Spectroscopy, Fourier Transform Infrared; Water | 2023 |
Interactions between modified fullerenes and proteins in cancer nanotechnology.
Topics: Carcinogenesis; Fullerenes; Humans; Nanostructures; Nanotechnology; Neoplasms; Proteins | 2023 |
Nanocomposite fibers based on cellulose acetate loaded with fullerene for cancer therapy: preparation, characterization and in-vitro evaluation.
Topics: Caco-2 Cells; Cellulose; Fullerenes; Humans; Nanocomposites; Neoplasms | 2023 |
Near-Infrared Light-Harvesting Fullerene-Based Nanoparticles for Promoted Synergetic Tumor Phototheranostics.
Topics: Animals; Fullerenes; Humans; Hyperthermia, Induced; Infrared Rays; Mice; Nanoparticles; Neoplasms; Photochemotherapy; Reactive Oxygen Species; Theranostic Nanomedicine | 2019 |
Functional Gadofullerene Nanoparticles Trigger Robust Cancer Immunotherapy Based on Rebuilding an Immunosuppressive Tumor Microenvironment.
Topics: Fullerenes; Humans; Immunotherapy; Nanoparticles; Neoplasms; Tumor Microenvironment | 2020 |
Hand-ground fullerene-nanodiamond composite for photosensitized water treatment and photodynamic cancer therapy.
Topics: Animals; Fullerenes; Mice; Nanodiamonds; Neoplasms; Photochemotherapy; Water Purification | 2021 |
Design and synthesis of highly fluorescent and stable fullerene nanoparticles as probes for folic acid detection and targeted cancer cell imaging.
Topics: Animals; Chlorocebus aethiops; COS Cells; Drug Stability; Fluorescent Dyes; Folic Acid; Fullerenes; HeLa Cells; Humans; Microscopy, Fluorescence; Neoplasms; Particle Size | 2021 |
B
Topics: Antineoplastic Agents; Drug Delivery Systems; Fluorouracil; Fullerenes; Humans; Models, Molecular; Neoplasms; Quantum Theory; Thermodynamics | 2017 |
Cycloaddition reactions of pristine and endohedral fullerene molecules: possible anticancer activity.
Topics: Animals; Antineoplastic Agents; Fullerenes; Humans; Neoplasms | 2018 |
Gadolinium Metallofullerene-Based Activatable Contrast Agent for Tumor Signal Amplification and Monitoring of Drug Release.
Topics: Animals; Contrast Media; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fullerenes; Gadolinium; HeLa Cells; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Mice; Nanoparticles; Neoplasms; Polymers; Tumor Microenvironment | 2019 |
Photo-triggered gadofullerene: enhanced cancer therapy by combining tumor vascular disruption and stimulation of anti-tumor immune responses.
Topics: Animals; Antineoplastic Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Dendritic Cells; Female; Fullerenes; Human Umbilical Vein Endothelial Cells; Humans; Immune System; Interleukin-12; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Photosensitizing Agents; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2019 |
Synthesis and In Vitro Biological Evaluation of Psoralen-Linked Fullerenes.
Topics: Cell Line, Tumor; DNA Cleavage; Fullerenes; Furocoumarins; Humans; Molecular Structure; Mutagenicity Tests; Neoplasms; Photochemotherapy; Reactive Oxygen Species; Salmonella typhimurium; Singlet Oxygen | 2019 |
A fullerene-based multi-functional nanoplatform for cancer theranostic applications.
Topics: Animals; Drug Delivery Systems; Folic Acid; Fullerenes; Humans; Hypothermia, Induced; Magnetic Resonance Imaging; Magnetite Nanoparticles; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanocomposites; Neoplasms; Photochemotherapy; Polyethylene Glycols | 2014 |
Dual inhibitory pathways of metallofullerenol Gd@C₈₂(OH)₂₂ on matrix metalloproteinase-2: molecular insight into drug-like nanomedicine.
Topics: Amino Acid Sequence; Binding Sites; Catalytic Domain; Fullerenes; Gadolinium; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Models, Molecular; Molecular Sequence Data; Nanomedicine; Neoplasms; Protein Binding; Protein Conformation; Sequence Alignment; Signal Transduction | 2014 |
Dual role of photosensitizer and carrier material of fullerene in micelles for chemo-photodynamic therapy of cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Fullerenes; Mice; Micelles; Microscopy, Electron, Transmission; Neoplasms; Photochemotherapy; Photosensitizing Agents | 2014 |
Switching of the triplet excited state of rhodamine-C60 dyads.
Topics: Acids; Coloring Agents; Fullerenes; HeLa Cells; Humans; Light; Neoplasms; Photosensitizing Agents; Rhodamines | 2014 |
Synthesis and properties of novel water-soluble fullerene-glycine derivatives as new materials for cancer therapy.
Topics: Biocompatible Materials; Carbon; Cell Line, Tumor; Drug Design; Flow Cytometry; Fullerenes; Glycine; HeLa Cells; Humans; Magnetic Resonance Spectroscopy; Microscopy, Electron, Scanning; Nanostructures; Neoplasms; Solubility; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Thermogravimetry; Water | 2015 |
Effects of Two Fullerene Derivatives on Monocytes and Macrophages.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Fullerenes; Humans; Hydrophobic and Hydrophilic Interactions; Macrophages; Monocytes; Neoplasms; Nitrogen; Receptors, Purinergic P2X7 | 2015 |
Polyhydroxylated fullerenols regulate macrophage for cancer adoptive immunotherapy and greatly inhibit the tumor metastasis.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytokines; Fullerenes; Gadolinium; Humans; Immunotherapy, Adoptive; Macrophages; Mice; Mitochondria; Nanoparticles; Neoplasm Metastasis; Neoplasms | 2016 |
Synergistic Effect of Human Serum Albumin and Fullerene on Gd-DO3A for Tumor-Targeting Imaging.
Topics: Animals; Contrast Media; Fullerenes; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Neoplasms; Organometallic Compounds; Serum Albumin | 2016 |
Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Female; Fullerenes; Gadolinium; Humans; Lipid Peroxidation; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Mitochondria; Nanostructures; Nanotechnology; Neoplasms; Organometallic Compounds; Oxidative Stress; Oxidoreductases; Reactive Oxygen Species; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2008 |
Potent angiogenesis inhibition by the particulate form of fullerene derivatives.
Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Down-Regulation; Female; Fullerenes; Mice; Microvessels; Nanoparticles; Neoplasms | 2010 |
Gain of a 500-fold sensitivity on an intravital MR contrast agent based on an endohedral gadolinium-cluster-fullerene-conjugate: a new chance in cancer diagnostics.
Topics: Contrast Media; Fullerenes; Gadolinium; Humans; Magnetic Resonance Imaging; Neoplasms | 2010 |
Low-toxic and safe nanomaterials by surface-chemical design, carbon nanotubes, fullerenes, metallofullerenes, and graphenes.
Topics: Antineoplastic Agents; Contrast Media; Fullerenes; Graphite; Humans; Nanoparticles; Nanotubes, Carbon; Neoplasms; Reactive Oxygen Species; Surface Properties | 2011 |
Photodynamic therapy with fullerenes in vivo: reality or a dream?
Topics: Animals; Fullerenes; Humans; Hydroxyl Radical; Light; Mice; Models, Animal; Nanomedicine; Neoplasms; Photochemistry; Photochemotherapy; Photosensitizing Agents; Singlet Oxygen; Superoxides; Water | 2011 |
Photodynamic therapy using glycol chitosan grafted fullerenes.
Topics: Animals; Cell Line, Tumor; Chitosan; Female; Fullerenes; Humans; Light; Mice; Mice, Nude; Neoplasms; Photochemotherapy; Photosensitizing Agents | 2012 |
PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor.
Topics: Administration, Intravenous; Animals; Apoptosis; Body Weight; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Delivery Systems; Endocytosis; Female; Folic Acid; Fullerenes; Humans; Male; Mice; Mice, Inbred BALB C; Neoplasms; Particle Size; Polyethyleneimine; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Taxoids; Tissue Distribution; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Hyaluronated fullerenes with photoluminescent and antitumoral activity.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Fluorescent Dyes; Fullerenes; HCT116 Cells; Humans; Hyaluronic Acid; Lasers; Mice; Mice, Nude; Neoplasms; Photosensitizing Agents; Spectroscopy, Near-Infrared; Transplantation, Heterologous | 2013 |
Non-destructive inhibition of metallofullerenol Gd@C(82)(OH)(22) on WW domain: implication on signal transduction pathway.
Topics: Antineoplastic Agents; Binding Sites; Contrast Media; Down-Regulation; Extracellular Matrix; Fullerenes; Humans; Ligands; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Molecular Dynamics Simulation; Neoplasms; Proline-Rich Protein Domains; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Signal Transduction | 2012 |
Antioxidative function and biodistribution of [Gd@C82(OH)22]n nanoparticles in tumor-bearing mice.
Topics: Animals; Antioxidants; Blood Coagulation; Carcinoma, Hepatocellular; Female; Fullerenes; Gadolinium; Liver; Liver Neoplasms, Experimental; Mice; Mice, Inbred Strains; Nanostructures; Nanotechnology; Neoplasms; Organometallic Compounds; Oxidative Stress; Tissue Distribution; Xenograft Model Antitumor Assays | 2006 |
Preparation of PEG-conjugated fullerene containing Gd3+ ions for photodynamic therapy.
Topics: Animals; Cell Line, Tumor; Chelating Agents; Cobalt Radioisotopes; Contrast Media; Excipients; Fullerenes; Gadolinium; Injections, Intravenous; Magnetic Resonance Imaging; Mice; Neoplasm Transplantation; Neoplasms; Pentetic Acid; Photochemotherapy; Polyethylene Glycols; Superoxides | 2007 |
Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism.
Topics: Animals; Apoptosis; Cell Line, Tumor; Fullerenes; Mice; Molecular Structure; Neoplasms; Photochemistry; Photosensitizing Agents; Singlet Oxygen; Superoxides; Water | 2007 |